Bio Developments

Chameleon’s immunomodulatory tech wins breakthrough award

by admin
November 7, 2022

Adeno-associated virus (AAV)-based gene therapy uses ‘gutted’ non-pathogenic viruses to carry good genes to cells to replace broken versions of the genes. However, normal immune… Read More »Chameleon’s immunomodulatory tech wins breakthrough award

CSL enters licensing agreement with Arcturus Therapeutics for self-amplifying mRNA technology

by admin
November 2, 2022

Via its vaccine subsidiary CSL Seqirus, CSL will use Arcturus’ tech to support the research, development, manufacture and commercialization of vaccines for COVID-19, influenza, pandemic… Read More »CSL enters licensing agreement with Arcturus Therapeutics for self-amplifying mRNA technology